Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology|September 6, 2023
Myocardial extracellular volume fraction is positively associated with activated monocyte subsets among cART-treated persons living with HIV in South AfricaTess E Peterson, Muki Shey, Nomawethu Masina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2024
Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort StudyTomas O Jensen, Katrina Harper, Shaili Gupta, et al.
Open Forum Infectious Diseases|February 15, 2020
Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical TrialJason V Baker, Julian Wolfson, Tess Peterson, et al.
Journal of the American Heart Association|May 24, 2017
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) TrialJason V Baker, Shweta Sharma, Amit C Achhra, et al.
Open Forum Infectious Diseases|December 13, 2016
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) TrialJason V Baker, Katherine Huppler Hullsiek, Nicole Wyman Engen, et al.
AIDS Research and Human Retroviruses|August 28, 2020
The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and AgingStephanie Shiau, Alexis A Bender, Jane A O'Halloran, et al.
Open Forum Infectious Diseases|September 29, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START studyNila J Dharan, Shweta Sharma, Alejandro Arenas-Pinto, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infectionPeter A Crawford, Joshua Rhein, Jeffrey G Chipman, et al.
Open Forum Infectious Diseases|May 22, 2023
Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic SuppressionJose R Castillo-Mancilla, Mary Morrow, Peter W Hunt, et al.
Current HIV Research|July 19, 2014
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ functionKaku A So-Armah, Joyce Chang, Charles Alcorn, et al.
Pageof 11